ASCO GU 2026: Updates in metastatic prostate cancer
Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of March 01 - 06, 2021
Alerts this week cover papers from New England, JAMA Oncology, ESMO Open and Lancet Oncology.
Dr Morgan also highlights the approval of lorlatinib to first line for ALK non-small cell lung cancer and encourages.
You can watch Dr Morgan's previous roundup here.
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer
ASCO GU 2026: Updates in metastatic prostate cancer
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ESMO 2024: Highlights and analysis
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
OncoAlert round up July 28th to August 3rd, 2023
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer